Table 2 Detailed clinical history of patients
Patient | Age/gender | Type of cancer | Previous therapy | Ongoing treatment | Analgesic score (type) | Analgesic score (quantity) |
|---|---|---|---|---|---|---|
1 | 51/M | mCRPC | First- and second-generation anti-androgens, chemotherapy | Androgen synthesis inhibitor | Morphine | 2 |
2 | 25/F | Non-small cell right lung cancer | Lobectomy, chemotherapy, radiotherapy | – | Morphine | 2 |
3 | 60/M | Right breast cancer | Chemotherapy, radiotherapy | – | Morphine | 2 |
4 | 44/F | B/L breast cancer | B/L breast mastectomy, chemotherapy, radiotherapy, monoclonal antibody therapy | – | Morphine | 2 |
5 | 61/M | Right breast cancer | Hormonal therapy, chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 3 |
6 | 70/M | mCRPC | Medical castration, first-generation anti-androgen therapy, chemotherapy, radiotherapy | Second-generation anti-androgens | Morphine | 4 |
7 | 63/M | mCRPC | B/L orchidectomy, first-generation anti-androgens, chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
8 | 60/F | Small-cell lung cancer | Chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 3 |
9 | 44/F | Right breast cancer | Right breast mastectomy, hormonal therapy, chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
10 | 65/F | Left breast cancer | Hormonal therapy, chemotherapy, | – | Atypical opioids and non-morphine opioids | 2 |
11 | 33/F | Right breast cancer | Chemotherapy, radiotherapy | – | Morphine | 2 |
12 | 74/M | mCRPC | Radical Prostatectomy, B/L orchidectomy, first-generation anti-androgens, chemotherapy, | - | Atypical opioids and non-morphine opioids | 2 |
13 | 45/F | Left breast cancer | Left breast modified radical mastectomy, hormonal therapy, chemotherapy, radiotherapy, | – | Atypical opioids and non-morphine opioids | 3 |
14 | 27/F | B/L breast cancer | Hormonal therapy, B/L mastectomy, chemotherapy, radiotherapy, | – | Morphine | 2 |
15 | 47/F | Left breast cancer | Hormonal therapy, chemotherapy, radiotherapy, antibody therapy | – | Other NSAIDs | 1 |
16 | 27/F | Left breast cancer | chemotherapy, radiotherapy, | – | Other NSAIDs | 2 |
17 | 55/M | mCRPC | B/L orchidectomy, first- and second-generation anti-androgens, chemotherapy, radiotherapy | Androgen synthesis inhibitors | Other NSAIDs | 3 |
18 | 44/F | Left breast cancer | Left modified radical mastectomy, chemotherapy, radiotherapy | – | Morphine | 2 |
19 | 58/F | Right breast cancer | Rt breast mastectomy chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 4 |
20 | 24/M | Squamous cell cancer of lung | Surgery, chemotherapy | – | Morphine | 2 |
21 | 55/F | Left breast cancer | Surgery, chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
22 | 55/F | Squamous cell cancer of lung | Chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
23 | 54/F | Right breast cancer | Chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 3 |
24 | 40/F | Right breast cancer | Chemotherapy, radiotherapy | – | Morphine | 2 |
25 | 54/M | mCRPC | Medical castration, Chemotherapy, radiotherapy | Androgen-synthesis inhibitors | Morphine | 2 |
26 | 63/F | B/L breast cancer | Bilateral mastectomy, chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
27 | 47/F | Right breast cancer | Right breast mastectomy, hormonal therapy, chemotherapy, radiotherapy | – | Morphine | 2 |
28 | 50/M | Right breast cancer | Right modified radical mastectomy, chemotherapy, radiotherapy | – | Morphine | 2 |
29 | 40/F | B/L breast cancer | Hormonal therapy, chemotherapy, radiotherapy | – | Morphine | 2 |
30 | 75/M | mCRPC | B/L orchidectomy, chemotherapy, first- and second-generation anti-androgens, radiotherapy | None | Atypical opioids and non-morphine opioids | 2 |
31 | 67/M | mCRPC | B/L orchidectomy, first-generation anti-androgens Chemotherapy, radiotherapy, | Second-generation anti-androgens | Atypical opioids and non-morphine opioids | 2 |
32 | 78/M | mCRPC | B/L orchidectomy, chemotherapy | Androgen synthesis inhibitor | Atypical opioids and non-morphine opioids | 2 |
33 | 48/F | B/L breast cancer | Chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
34 | 40 | Right breast cancer | Right modified radical mastectomy, chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
35 | 70/M | mCRPC | Medical castration, chemotherapy, radiotherapy | Androgen-synthesis inhibitors | Morphine | 2 |
36 | 43/M | Non-small cell lung cancer of the right lung | Chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
37 | 32/F | Right breast cancer | Right breast mastectomy chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
38 | 67/F | Right breast cancer | Right modified radical mastectomy, hormonal therapy chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 2 |
39 | 30/F | Small cell cancer of lung | Chemotherapy, radiotherapy | – | Atypical opioids and non-morphine opioids | 3 |
40 | 76/M | mCRPC | B/L orchidectomy, first-generation anti-androgens, chemotherapy, radiotherapy | Second-generation anti-androgens | Atypical opioids and non-morphine opioids | 2 |